- Programs & Services
- Cost Management
- Specialty Management
- Care Management
- Member Engagement
- Health Plan Client Engagement
The Drug Trend Report
Drug Trend Report - Overall Trend
We Partner with Clients to Consistently Lower Trend
80.5% of Clients Had Less Than 10% Trend
63.1% of Clients Had Less Than 10% Trend 2 Years Running
Clinical Integrity and Best Practices Drive Our Approach
Our approach begins with the latest clinical research, guidelines and best practices – and our formulary decisions are managed by a committee of independent, unaffiliated clinical pharmacists and physicians. Across every therapeutic category, we strive to achieve the lowest net cost for our clients and their plan members. Getting there means managing the two fundamental forces behind drug spending: price and utilization.
Negotiating to Lower Prices
We bring our size, scale and expertise as the largest purchaser of prescription drugs in the United States to the negotiating table – working to reach the lowest prices possible with drug manufacturers.
Getting The Mix Right
We apply our innovation to ensure the most effective, lowest-cost medications are used. Whether it’s taking the lead in adding biosimilars or ensuring that less costly, clinically equivalent generics get preference, we use our formularies to manage costs.
Ensuring Appropriate Treatment Use
We guide coverage toward the treatments most likely to deliver the best outcomes – avoiding wasted time and money on less effective medications.
We monitor the market for unjustifiably high-priced drugs with less costly clinical equivalents, removing them from our formularies. And we work with members to support optimal adherence, prevent stockpiling and minimize wasted spend.
Lowest Net Cost